References
- Boxenmaum 1982. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm. 10:201–227.
- Clewell HJ, Campbell JL, Van Landingham C, Franzen A, Yoon M, Dodd DE, Andersen ME, Gentry PR. 2019. Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene. Inhal Toxicol. 31:468–483.
- Filser JG, Klein D. 2018. A physiologically based toxicokinetic model for inhaled ethylene and ethylene oxide in mouse, rat and human. Toxicol Lett. 286:54–79.
- Hattis D. 1987. A pharmacokinetic/mechanism-based analysis of the carcinogenic risk of ethylene oxide. Cambridge (MA): Center for Technology, Policy and Industrial Development, MIT. National Technical Information Service. CTPID 87-1, NTIS/PB88-188784.
- Spearman John R. 2005. Body size, energy metabolism and lifespan. J Exp Biol. 208:1717–1730.